reference/9152256

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9152256

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial
endingPage	362
issn	0306-5251 1365-2125
issueIdentifier	4
pageRange	355-362
publicationName	British Journal of Clinical Pharmacology
startingPage	355
bibliographicCitation	Dingemanse J, Clozel M, Van Giersbergen PLM. Pharmacokinetics and pharmacodynamics of tezosentan, an intravenous dual endothelin receptor antagonist, following chronic infusion in healthy subjects. Brit J Clinical Pharma. 2002 Apr;53(4):355–62. doi: 10.1046/j.1365-2125.2002.01158.x.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db2ab8e85f776afbe91a6f77ad8c4932 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e39caee98833602758135dbece0ef9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5ffb6d7d2ba0f07592f05bacbcadb14
date	200204
identifier	https://doi.org/10.1046/j.1365-2125.2002.01158.x https://pubmed.ncbi.nlm.nih.gov/PMC1874269 https://pubmed.ncbi.nlm.nih.gov/11966665
isPartOf	https://portal.issn.org/resource/ISSN/1365-2125 https://portal.issn.org/resource/ISSN/0306-5251 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1743
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Pharmacokinetics and pharmacodynamics of tezosentan, an intravenous dual endothelin receptor antagonist, following chronic infusion in healthy subjects
discusses	http://id.nlm.nih.gov/mesh/M0218648 http://id.nlm.nih.gov/mesh/M0022559 http://id.nlm.nih.gov/mesh/M0331838 http://id.nlm.nih.gov/mesh/M0219577 http://id.nlm.nih.gov/mesh/M0021253 http://id.nlm.nih.gov/mesh/M0587496 http://id.nlm.nih.gov/mesh/M0018233
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014665Q000493 http://id.nlm.nih.gov/mesh/D065128 http://id.nlm.nih.gov/mesh/D014665Q000494 http://id.nlm.nih.gov/mesh/D013777Q000494 http://id.nlm.nih.gov/mesh/D011725Q000493 http://id.nlm.nih.gov/mesh/D011725Q000494 http://id.nlm.nih.gov/mesh/D013777Q000493
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D001794Q000187 http://id.nlm.nih.gov/mesh/D007262 http://id.nlm.nih.gov/mesh/D014665Q000009 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D013777Q000008 http://id.nlm.nih.gov/mesh/D006207 http://id.nlm.nih.gov/mesh/D006261Q000139 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D013777Q000009 http://id.nlm.nih.gov/mesh/D044022 http://id.nlm.nih.gov/mesh/D014665Q000008 http://id.nlm.nih.gov/mesh/D011725Q000009 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D044023 http://id.nlm.nih.gov/mesh/D011725Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151174 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8e38613f28d11a079c0276d233e37ef4 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7922 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16212950 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129317778

Showing number of triples: 1 to 60 of 60.